FreeCME
ABSTRACT & COMMENTARY

Bendamustine-rituximab compared with R-CHOP or R-CVP for first-line treatment of indolent NHL

June 1, 2014
/ Print / Reprints /
| Share More
/ Text Size+

Optimizing the Management of Relapsed Refractory Chronic Lymphocytic Leukemia

OncologyCME

thumbnail

Partner with Us

freeCME.com® provides unparalleled opportunities for partners.